NYSE · Medical - Distribution

McKesson Corporation (MCK) Stock

$1000.77 -1.14% NYSE: MCK Healthcare

Valuation

MetricValue
Price$1000.77
Market Cap$116.68B
P/E Ratio27.06
P/B Ratio-28.43
P/S Ratio0.29
EPS (TTM)$38.38
52-Week High$1030.27
52-Week Low$723.68
Dividend Yield0.37%

Financials & Margins

MetricValue
ROE-194.39%
ROA5.20%
ROCE37.02%
Gross Margin1.54%
Operating Margin1.54%
Net Margin1.12%
Debt/Equity-2.76
Current Ratio0.85

Annual Financials (USD)

Metric20222023202420252026
Revenue$264.0B$276.7B$309.0B$359.1B$403.4B
Operating Profit$2.7B$4.5B$3.9B$4.4B$6.5B
Net Profit$1.1B$3.6B$3.0B$3.3B$4.8B
EPS$7.23$25.04$22.39$25.72$38.38
Op Margin1.0%1.6%1.3%1.2%1.6%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$63.3B$62.3B$67.4B$75.1B$82.3B
Total Liabilities$65.1B$63.8B$69.0B$76.8B$83.2B
Cash$3.5B$4.7B$4.6B$5.7B$4.0B
Borrowings$7.5B$7.3B$7.4B$7.4B$8.6B

Latest News

2 Profitable Stocks Worth Investigating and 1 We Turn Down StockStory · Jul 15, 2026 McKesson (MCK) Stock Dips While Market Gains: Key Facts Zacks · Jul 14, 2026 Cheniere Appoints Britt Vitalone to Board of Directors Business Wire · Jul 14, 2026 Leerink Partners Adjusts Price Target on McKesson to $950 From $970, Maintains Outperform Rating MT Newswires · Jul 14, 2026 Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry Zacks · Jul 14, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$4.4B$5.2B$4.3B$6.1B$6.2B
Investing Cash Flow$-624.0M$-1.1B$-1.8B$-1.6B$-4.2B
Financing Cash Flow$-4.9B$-4.0B$-3.2B$-3.7B$-5.1B
Net Cash Flow$-2.5B$744.0M$-94.0M$1.4B$-2.0B
Free Cash Flow$3.9B$4.6B$3.6B$5.2B$5.4B

Valuation & Return Ratios

MetricValue
PEG Ratio0.55
EV / EBITDA17.02
FCF Yield5.22%
Quick Ratio0.52
Interest Coverage43.49
Return 1Y26.70%
Return 3Y124.34%
Return 5Y410.20%

Ownership

Insiders Held0.05%
Institutions Held95.69%
Institutions Float Held95.74%
Institutional HolderSharesReport Date
Blackrock Inc.11,418,3842026-03-31
Vanguard Capital Management LLC7,960,7242026-03-31
State Street Corporation5,731,7562026-03-31
FMR, LLC3,603,4232026-03-31
JPMORGAN CHASE & CO3,268,3402026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACHAccendra Health, Inc. $0.22 +3.08% -0.08 $16.71M 0.00%
CAHCardinal Health, Inc. $249.57 -2.37% 34.08 $57.79B 0.83%
CORCencora, Inc. $331.00 -2.21% 22.21 $63.16B 0.80%
SHPMYShanghai Pharmaceuticals Holding Co., Ltd $7.34 +0.00% 10.56 $5.44B 6.95%
SHTDYSinopharm Group Co. Ltd. $10.83 -1.81% 6.40 $6.76B 4.71%

About McKesson Corporation

McKesson Corporation is led by CEO Brian S. Tyler, employs 44,000 people, headquartered in Irving, US, publicly traded since 1994.

McKesson Corporation (MCK) stock trades at $1000.77 with a market capitalization of $116.68B. The stock is valued at a price-to-earnings (P/E) ratio of 27.06, a negative price-to-book of -28.43, reflecting negative shareholders' equity, price-to-sales of 0.29. Over the past 52 weeks the stock has ranged between $723.68 and $1030.27, and currently trades 2.9% below its 52-week high. It pays a dividend yielding 0.37%.

On profitability, McKesson Corporation generates a return on equity (ROE) of -194.39% (not meaningful, as shareholders' equity is negative), return on capital employed of 37.02%, an operating margin of 1.54%, a net profit margin of 1.12%.

In its most recent fiscal year, McKesson Corporation reported annual revenue of $403.4B, net profit of $4.8B. Revenue grew at an average annual rate of 11.1% over the last 5 fiscal years.

The balance sheet shows a debt-to-equity ratio of -2.76 (negative because shareholders' equity is negative), a current ratio of 0.85, total assets of $82.3B, $4.0B in cash and equivalents.

MCK has an average daily trading volume of 963,841 shares, a beta of 0.30 (historically less volatile than the overall market).

McKesson Corporation by the numbers, 2017–2026

Between 2017 and 2026 McKesson Corporation reported revenue of $198.5B rising to $403.4B, a change of +103.2% across 10 years. Compounded, revenue has grown 11.1% a year over five years, 13.4% over three, 12.4% over the last twelve months. Net profit fell to $4.8B.

Operating margin went from 1.7% in 2017 to 1.6% in 2026, essentially unchanged. The most recent net margin is 1.12%. On a trailing twelve-month basis to Jun '26, revenue is $411.0B and net profit $4.6B.

Borrowings held roughly flat from $8.5B to $8.6B, cash from operations was $6.2B in the latest year, positive in 10 of the last 10.

Return on equity has averaged -154.2% over five years, and was -219.2% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

McKesson Corporation (MCK) — frequently asked questions

What is McKesson Corporation (MCK) stock price today?

McKesson Corporation (MCK) is currently trading at $1000.77, down 1.14% today.

What is MCK P/E ratio?

McKesson Corporation's P/E ratio is 27.06. This is between 15x and 30x, around the typical market average of roughly 18-22x.

What is MCK return on equity (ROE)?

McKesson Corporation's return on equity (ROE) is -194.39%. ROE measures net income relative to shareholders' equity. Shareholders' equity is negative, so ROE is not a meaningful measure for this company.

What is McKesson Corporation's market cap?

McKesson Corporation has a market capitalization of $116.68B.

Does MCK pay a dividend?

Yes. McKesson Corporation currently yields 0.37%. Yield moves with the share price, so it changes daily even when the payment does not.

How much debt does MCK carry?

McKesson Corporation has a debt-to-equity ratio of -2.76. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is MCK's profit margin?

McKesson Corporation reports a net profit margin of 1.12% — the share of revenue left after every cost, including tax and interest.

What sector is MCK in?

McKesson Corporation is classified under Healthcare, in the Medical - Distribution industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is MCK listed on?

McKesson Corporation trades on NYSE under the ticker MCK.

What is MCK's 52-week range?

Over the last year McKesson Corporation has traded between $723.68 and $1030.27.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens MCK currently matches

On the figures above, McKesson Corporation passes the filters for 9 of our ready-made screens, among them Low Debt Stocks, Large Cap Stocks, Stocks With EPS Above $10. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Low Debt StocksLarge Cap StocksStocks With EPS Above $10High ROCE StocksLarge Cap Dividend StocksNYSE Listed StocksStocks Over $500Stocks With PE Under 30Negative Working Capital Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.